コンパニオンアニマル用医薬品の世界市場レポート 2025年

コンパニオンアニマル用医薬品の市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.3％で265億2,000万米ドルに成長します。予測期間の成長は、ペットのための個別化医療、遠隔医療と遠隔獣医療サービス、栄養と栄養補助食品への注力、ワンヘルスイニシアチブ、獣医療診断サービスの拡大に起因しています。予測期間の主な動向には、獣医学の進歩、高齢化するペットに特化した治療法、規制遵守と安全基準、共同研究やパートナーシップなどがあります。

人獣共通感染症の罹患率の上昇がコンパニオンアニマル用医薬品市場の成長を促進すると予測されます。脊椎動物と人間の間でトランスミッションが可能な人獣共通感染症は、公衆衛生上の大きな課題となっています。これに対して製薬業界は、これらの疾病と闘い、トランスミッションのリスクを低減するために、健康原則に沿った最新の戦略を展開しています。欧州疾病予防管理センターによる2022年12月の報告書は、カンピロバクテリウム症やその他の人獣共通感染症の有病率の増加を強調し、医薬品による介入の必要性を強調しています。

コンパニオンアニマル用医薬品市場は、ペット飼育の急増に後押しされ、成長する態勢にあります。ペットの所有は、人間が動物の世話に責任を持つことを意味し、増加傾向にあります。この市場は、ペットの飼い主層の拡大と、コンパニオンアニマルの健康のための予防措置、診断、治療の重要性に対する認識の高まりから利益を得ています。2022年10月に米国獣医師会が発表した報告書によると、少なくとも猫を1匹飼う家庭が大幅に増加しています。獣医学的支出の増加に支えられたこの動向は、市場の成長可能性を裏付けています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のコンパニオンアニマル用医薬品 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のコンパニオンアニマル用医薬品市場：成長率分析
• 世界のコンパニオンアニマル用医薬品市場の実績：規模と成長, 2019-2024
• 世界のコンパニオンアニマル用医薬品市場の予測：規模と成長, 2024-2029, 2034F
• 世界のコンパニオンアニマル用医薬品総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のコンパニオンアニマル用医薬品市場：動物タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 犬
• 猫
• 馬
• その他のペット
• 世界のコンパニオンアニマル用医薬品市場：適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 感染症
• 皮膚疾患
• 疼痛
• 整形外科疾患
• 行動障害
• その他の適応症
• 世界のコンパニオンアニマル用医薬品市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 動物病院
• 獣医クリニック
• 小売薬局
• 世界のコンパニオンアニマル用医薬品市場：犬のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ワクチン
• 駆虫薬
• 抗炎症薬
• 世界のコンパニオンアニマル用医薬品市場：猫のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ワクチン
• 駆虫薬
• 抗炎症薬
• 世界のコンパニオンアニマル用医薬品市場：馬のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ワクチン
• 駆虫薬
• 抗炎症薬
• 世界のコンパニオンアニマル用医薬品市場：その他のペット動物のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ワクチン
• 駆虫薬
• その他の治療法

第7章 地域別・国別分析

• 世界のコンパニオンアニマル用医薬品市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のコンパニオンアニマル用医薬品市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• コンパニオンアニマル用医薬品市場：競合情勢
• コンパニオンアニマル用医薬品市場：企業プロファイル
  • Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • Ceva Sante Animale Overview, Products and Services, Strategy and Financial Analysis
  • Chanelle Pharma Overview, Products and Services, Strategy and Financial Analysis
  • Eco Animal Health Group PLC Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Ashish Life Science Pvt. Ltd.
• Endovac Animal Health
• Hipra Laboratories
• Indian Immunologicals Ltd.
• Inovet Group
• Kyoritsu Seiyaku Corporation
• Lutim Pharma Pvt. Ltd.
• Merck & Co. Inc.
• Norbrook Laboratories Ltd.
• Tianjin Ringpu Bio-Technology Co. Ltd.
• Vetoquinol S.A.
• Virbac S.A.
• Zoetis Inc.
• Agrolabo S.p.A.
• ALS Pvt. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• コンパニオンアニマル用医薬品市場2029：新たな機会を提供する国
• コンパニオンアニマル用医薬品市場2029：新たな機会を提供するセグメント
• コンパニオンアニマル用医薬品市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Companion animal pharmaceuticals involve the pharmaceutical medication process where animal pharmacists recommend medications, fill prescriptions, and manage drug therapies for animals. It is utilized in the diagnosis, mitigation, and treatment of various diseases in animals.

The main types of companion animal pharmaceuticals include medications for dogs, cats, horses, and other companion animals. Dogs are highly variable carnivorous domesticated mammals closely related to the common wolf. The indications for these pharmaceuticals cover infectious diseases, dermatologic diseases, pain management, orthopedic diseases, behavioral issues, and other conditions. These medications are typically sold through various distribution channels such as veterinary hospitals, veterinary clinics, and retail pharmacies.

The companion animal pharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides companion animal pharmaceuticals market statistics, including companion animal pharmaceuticals industry global market size, regional shares, competitors with a companion animal pharmaceuticals market share, detailed companion animal pharmaceuticals market segments, market trends and opportunities, and any further data you may need to thrive in the companion animal pharmaceuticals industry. This companion animal pharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The companion animal pharmaceuticals market size has grown strongly in recent years. It will grow from $16.49 billion in 2024 to $17.9 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to humanization of pets, preventive healthcare measures, rise in pet insurance, changing lifestyle and urbanization, zoonotic disease concerns, zoonotic disease concerns, veterinary healthcare accessibility.

The companion animal pharmaceuticals market size is expected to see rapid growth in the next few years. It will grow to $26.52 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to personalized medicine for pets, telehealth and remote veterinary services, focus on nutrition and nutraceuticals, one health initiatives, expansion of veterinary diagnostic services. Major trends in the forecast period include advancements in veterinary medicine, specialized therapeutics for aging pets, regulatory compliance and safety standards, collaborations and partnerships.

The rising incidence of zoonotic diseases is anticipated to drive growth in the companion animal pharmaceuticals market. Zoonotic illnesses, capable of transmission between vertebrate animals and humans, present a considerable public health challenge. In response, the pharmaceutical industry is deploying modern strategies aligned with health principles to combat these diseases and reduce transmission risks. A December 2022 report by the European Centre for Disease Prevention and Control underscores the increasing prevalence of Campylobacteriosis and other zoonotic diseases, highlighting the need for pharmaceutical interventions.

The companion animal pharmaceutical market is poised for growth, fueled by an upsurge in pet ownership. Pet ownership, signifying the human assumption of responsibility for animal care, is on the rise. The market benefits from an expanding pet owner base and a growing recognition of the importance of preventive measures, diagnostics, and treatments for companion animal health. A report from the American Veterinary Medical Association in October 2022 reveals a substantial increase in families owning at least one cat. The trend, supported by increased veterinary spending, underscores the market's growth potential.

The adoption of big data technologies is a noteworthy trend in the companion animal pharmaceuticals sector. Leading companies are actively developing technological solutions to fortify their market positions. Notably, Elanco Animal Health Incorporated and Ginkgo Bioworks launched BiomEdit in April 2022. This microbiome innovation company focuses on developing novel probiotics and related animal pharmaceuticals. The initiative extends to areas such as medicated feed ingredients, nutritional health, therapies for livestock and pets, and biosecurity technologies for monitoring animal illnesses.

Major companies in the companion animal pharmaceutical market are introducing innovative products, such as oral flea and tick treatments, to expand their customer bases, boost sales, and enhance revenue. Oral flea and tick products are medications administered orally to prevent or treat infestations in pets. For example, in October 2024, Elanco Animal Health Incorporated, a US-based pharmaceutical firm, received FDA approval for Credelio Quattro, a new chewable parasiticide formulated for dogs. This product provides monthly protection against six types of parasites, including fleas, ticks, and various internal worms. With the launch of Credelio Quattro, Elanco aims to offer a convenient, comprehensive solution for pet owners seeking broad-spectrum parasite control. This introduction underscores Elanco's commitment to addressing the rising demand for innovative and effective pet health solutions.

In July 2022, Dechra Pharmaceuticals completed the acquisition of Piedmont Animal Health for $210 million. This strategic move enhances Dechra's product portfolio for European and North American markets and augments its scientific and regulatory capabilities. Piedmont Animal Health, a US-based company specializing in companion animal pharmaceuticals, brings complementary offerings to further strengthen Dechra's position in the industry.

Major companies operating in the companion animal pharmaceuticals market are Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma, Eco Animal Health Group PLC, Ashish Life Science Pvt. Ltd., Endovac Animal Health, Hipra Laboratories, Indian Immunologicals Ltd., Inovet Group, Kyoritsu Seiyaku Corporation, Lutim Pharma Pvt. Ltd., Merck & Co. Inc., Norbrook Laboratories Ltd., Tianjin Ringpu Bio-Technology Co. Ltd., Vetoquinol S.A., Virbac S.A., Zoetis Inc., Agrolabo S.p.A., ALS Pvt. Ltd., Zydus Animal Health and Investments Limited, Eli Lilly and Company, IDEXX Laboratories Inc., Merial Limited, Novartis Animal Health Inc., Dechra Pharmaceuticals PLC, Aratana Therapeutics Inc., Phibro Animal Health Corporation, Kindred Biosciences Inc., Jaguar Health Inc., Nexvet Biopharma PLC, Sentinel Biomedical Inc., PetMed Express Inc., Neogen Corporation, Heska Corporation, Synbiotics Corporation, Eurovet Animal Health B.V., Vironova AB, Abaxis Inc., Bioiberica S.A.U., Putney Inc., Lohmann Animal Health International

North America was the largest region in the companion animal pharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the companion animal pharmaceuticals market report during the forecast period. The regions covered in the companion animal pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the companion animal pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The companion animal pharmaceuticals market includes revenues earned by entities by providing veterinary pharmaceuticals, vaccines, and health management tools. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Companion Animal Pharmaceuticals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on companion animal pharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for companion animal pharmaceuticals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The companion animal pharmaceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Animal Type: Dogs; Cats; Horses; Other Companion Animals
• 2) By Indication: Infectious Diseases; Dermatologic Diseases; Pain; Orthopedic Diseases; Behavioral Diseases; Other Indications
• 3) By Distribution Channels: Veterinary Hospitals; Veterinary Clinics; Retail Pharmacies
• Subsegments:
• 1)By Dogs: Vaccines; Antiparasitic; Anti-Inflammatory Drugs
• 2) By Cats: Vaccines; Antiparasitic; Anti-Inflammatory Drugs
• 3) By Horses: Vaccines; Antiparasitic; Anti-Inflammatory Drugs
• 4) By Other Companion Animals: Vaccines; Antiparasitic; Other Therapeutics
• Companies Mentioned: Elanco Animal Health Incorporated; Boehringer Ingelheim International GmbH; Ceva Sante Animale; Chanelle Pharma; Eco Animal Health Group PLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Companion Animal Pharmaceuticals Market Characteristics

3. Companion Animal Pharmaceuticals Market Trends And Strategies

4. Companion Animal Pharmaceuticals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Companion Animal Pharmaceuticals Growth Analysis And Strategic Analysis Framework

• 5.1. Global Companion Animal Pharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Companion Animal Pharmaceuticals Market Growth Rate Analysis
• 5.4. Global Companion Animal Pharmaceuticals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Companion Animal Pharmaceuticals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Companion Animal Pharmaceuticals Total Addressable Market (TAM)

6. Companion Animal Pharmaceuticals Market Segmentation

• 6.1. Global Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dogs
• Cats
• Horses
• Other Companion Animals
• 6.2. Global Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Diseases
• Dermatologic Diseases
• Pain
• Orthopedic Diseases
• Behavioral Diseases
• Other Indications
• 6.3. Global Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Veterinary Hospitals
• Veterinary Clinics
• Retail Pharmacies
• 6.4. Global Companion Animal Pharmaceuticals Market, Sub-Segmentation Of Dogs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vaccines
• Antiparasitic
• Anti-Inflammatory Drugs
• 6.5. Global Companion Animal Pharmaceuticals Market, Sub-Segmentation Of Cats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vaccines
• Antiparasitic
• Anti-Inflammatory Drugs
• 6.6. Global Companion Animal Pharmaceuticals Market, Sub-Segmentation Of Horses, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vaccines
• Antiparasitic
• Anti-Inflammatory Drugs
• 6.7. Global Companion Animal Pharmaceuticals Market, Sub-Segmentation Of Other Companion Animals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vaccines
• Antiparasitic
• Other Therapeutics

7. Companion Animal Pharmaceuticals Market Regional And Country Analysis

• 7.1. Global Companion Animal Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Companion Animal Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Companion Animal Pharmaceuticals Market

• 8.1. Asia-Pacific Companion Animal Pharmaceuticals Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Companion Animal Pharmaceuticals Market

• 9.1. China Companion Animal Pharmaceuticals Market Overview
• 9.2. China Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Companion Animal Pharmaceuticals Market

• 10.1. India Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Companion Animal Pharmaceuticals Market

• 11.1. Japan Companion Animal Pharmaceuticals Market Overview
• 11.2. Japan Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Companion Animal Pharmaceuticals Market

• 12.1. Australia Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Companion Animal Pharmaceuticals Market

• 13.1. Indonesia Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Companion Animal Pharmaceuticals Market

• 14.1. South Korea Companion Animal Pharmaceuticals Market Overview
• 14.2. South Korea Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Companion Animal Pharmaceuticals Market

• 15.1. Western Europe Companion Animal Pharmaceuticals Market Overview
• 15.2. Western Europe Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Companion Animal Pharmaceuticals Market

• 16.1. UK Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Companion Animal Pharmaceuticals Market

• 17.1. Germany Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Companion Animal Pharmaceuticals Market

• 18.1. France Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Companion Animal Pharmaceuticals Market

• 19.1. Italy Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Companion Animal Pharmaceuticals Market

• 20.1. Spain Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Companion Animal Pharmaceuticals Market

• 21.1. Eastern Europe Companion Animal Pharmaceuticals Market Overview
• 21.2. Eastern Europe Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Companion Animal Pharmaceuticals Market

• 22.1. Russia Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Companion Animal Pharmaceuticals Market

• 23.1. North America Companion Animal Pharmaceuticals Market Overview
• 23.2. North America Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Companion Animal Pharmaceuticals Market

• 24.1. USA Companion Animal Pharmaceuticals Market Overview
• 24.2. USA Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Companion Animal Pharmaceuticals Market

• 25.1. Canada Companion Animal Pharmaceuticals Market Overview
• 25.2. Canada Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Companion Animal Pharmaceuticals Market

• 26.1. South America Companion Animal Pharmaceuticals Market Overview
• 26.2. South America Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Companion Animal Pharmaceuticals Market

• 27.1. Brazil Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Companion Animal Pharmaceuticals Market

• 28.1. Middle East Companion Animal Pharmaceuticals Market Overview
• 28.2. Middle East Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Companion Animal Pharmaceuticals Market

• 29.1. Africa Companion Animal Pharmaceuticals Market Overview
• 29.2. Africa Companion Animal Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Companion Animal Pharmaceuticals Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Companion Animal Pharmaceuticals Market, Segmentation By Distribution Channels, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Companion Animal Pharmaceuticals Market Competitive Landscape And Company Profiles

• 30.1. Companion Animal Pharmaceuticals Market Competitive Landscape
• 30.2. Companion Animal Pharmaceuticals Market Company Profiles
  • 30.2.1. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Ceva Sante Animale Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Chanelle Pharma Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eco Animal Health Group PLC Overview, Products and Services, Strategy and Financial Analysis

31. Companion Animal Pharmaceuticals Market Other Major And Innovative Companies

• 31.1. Ashish Life Science Pvt. Ltd.
• 31.2. Endovac Animal Health
• 31.3. Hipra Laboratories
• 31.4. Indian Immunologicals Ltd.
• 31.5. Inovet Group
• 31.6. Kyoritsu Seiyaku Corporation
• 31.7. Lutim Pharma Pvt. Ltd.
• 31.8. Merck & Co. Inc.
• 31.9. Norbrook Laboratories Ltd.
• 31.10. Tianjin Ringpu Bio-Technology Co. Ltd.
• 31.11. Vetoquinol S.A.
• 31.12. Virbac S.A.
• 31.13. Zoetis Inc.
• 31.14. Agrolabo S.p.A.
• 31.15. ALS Pvt. Ltd.

32. Global Companion Animal Pharmaceuticals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Companion Animal Pharmaceuticals Market

34. Recent Developments In The Companion Animal Pharmaceuticals Market

35. Companion Animal Pharmaceuticals Market High Potential Countries, Segments and Strategies

• 35.1 Companion Animal Pharmaceuticals Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Companion Animal Pharmaceuticals Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Companion Animal Pharmaceuticals Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer